Tunes of Treatment:

Understanding the success of pharmaceutical musical ad campaigns

Henry Chapman, Research and Insights Analyst

In the United States, pharmaceutical companies invest heavily in musical jingles within their advertising campaigns to create memorable experiences. They do this for two reasons: first, music has a powerful effect on memory and can make an ad more likely to be remembered, and second, a catchy tune can differentiate a product in the highly competitive pharmaceutical market. These jingles represent these companies' "pull-up" strategies, or getting the consumer to talk to their doctor about medications and conditions versus targeting the doctors themselves for a "push-down" strategy.

The success of these "pull-up" campaigns like those for Jardiance and Skyrizi, which have become almost synonymous with their jingles, illustrates the effectiveness of this approach. Meanwhile, Ozempic demonstrates how a product's market presence can eventually transcend its musical origins, although the initial boost from its jingle likely contributed to its widespread recognition.

Pharmaceutical advertising investments comprise the second-largest TV and digital advertising spending category in the United States. With billions of dollars at stake, these companies have developed extensive social listening practices to monitor the public reaction to that spending and determine how well those advertisements have broken through the public consciousness. We'll look at three of the most extensive pharma advertising campaigns in the United States today: Jardiance (Type-2 diabetes), Skyrizi (Crohn's disease and plaque psoriasis), and Ozempic (Type-2 diabetes). We'll show you how using the traditional advertising jingle, Ozempic, Skyrizi, and Jardiance are inextricably linked to their musical jingles.

Overall pharma ad post volume

As is tradition, we'll start with an overall view of post volume across each drug. Your first takeaway should be just how much attention social media spends on Ozempic, a medication used to improve Type 2 diabetes with the unintended side effect of weight loss. We started covering Ozempic last year, and its growth has skyrocketed since then, with a 1,148% growth rate since the beginning of our sample.

Jardiance and Skyrizi have much lower post volumes than Ozempic. However, Jardiance has a high growth rate over the period, at 828% positive growth since March 2022. Skyrizi had comparably flat growth throughout our sample time with only 49%.

Figure 1: Comparative post volume across Jardiance, Skyrizi, and Ozempic (March 2022 through March 2024); Infegy Social Dataset.

Breakthrough ad campaigns for the drugs with a smaller online footprint

Now that we've examined the post volume growth, let's discuss the underlying words fueling that growth. Remember, our query was just for a generic conversation around these brands. In other words, we weren't targeting a particular branded campaign; we were looking at posts mentioning these three drugs. Figure 3 shows that Jardiance and Skyrizi mention that their commercials "broke through" the underlying conversation with the highly featured word “commercial”. Breakthroughs are highly significant within the social listening space, as they are visceral proof that your musical advertising campaign is having an effect. "Commercial" was the most prevalent topic attached to Jardiance.

On the other hand, we didn't see any topics related to Ozempic's musical advertisement. We looked more extensively at the Ozempic conversation and found it there, but you had to search for it. Paradoxically, this is an excellent sign for the marketing folks over at Ozempic - it means that their product has reached a point of recognition that it has outgrown its advertising campaign.

Figure 2: Comparative topics across Jardiance, Skyrizi, and Ozempic (March 2022 through March 2024); Infegy Social Dataset.

Hashtags attributed to each advertising campaign for more attribution clarity

Let's explore hashtags to gain a deeper understanding of the underlying granular topics people discuss when they mention each of these brands. We corroborate our findings above regarding Ozempic. Most post volumes revolve around Ozempic weight-loss conversation, with a tiny percentage about advertising campaigns or Type-2 diabetes. We also note the prevalence of competitor hashtags like "#mounjaro" and "#wegovy."

Figure 3: Ozempic-related hashtags (March 2022 through March 2024); Infegy Social Dataset.

Compared with Ozempic, Skyrizi, and Jardiance, hashtags are much more branded (and targeted in their musical commercials). Interestingly, we see co-branded hashtags (specifically TV shows like #househunters and #bachelorinparadise, where drug advertisements appear). We examined the underlying posts, and most seemed to be organic (e.g., TV viewers talking about the Skyrizi and Jardiance commercials). This type of musical commercial shows how your ad can break through the noise.

Figure 4: Skyrizi-related hashtags (March 2022 through March 2024); Infegy Social Dataset.

Takeaways for your brand

Pharmaceutical companies' investment in musical jingles is a powerful tool for creating memorable brand associations and distinguishing their products in a competitive market. The success of campaigns for Jardiance and Skyrizi underscores the effectiveness of these "pull-up" strategies, which aim to encourage consumers to initiate conversations with healthcare providers about medications and conditions. Ozempic, on the other hand, has such societal reach that organic conversation has overwhelmed their more branded content. Pharma brand strategists must know the underlying patterns and buzz surrounding their ad campaigns to validate their spending. Social listening tools like the Infegy product suite can help hear this buzz across branded and unbranded channels.